Magnetar Financial LLC Amgen Inc Transaction History

Magnetar Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.95 Million - $2.48 Million	8,529 New	8,529 $2.24 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $645,092 - $713,640	-2,942 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $585,104 - $669,599	2,942 New	2,942 $662,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $283,592 - $332,263	-1,336 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $2.25 Million - $2.5 Million	-9,649 Reduced 87.84%	1,336 $326,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $709,002 - $826,227	3,195 Added 41.01%	10,985 $2.73 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.69 Million - $2.01 Million	7,790 New	7,790 $1.79 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $388,733 - $453,776	-2,179 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $168,799 - $190,298	-911 Reduced 29.48%	2,179 $452,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $521,561 - $582,743	3,090	3,090 $537,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.